crainsnewyork article is is unusual in many ways, including

New Post Public Reply Private Reply Replies (2) Message Board
havasu78 lorbas #64613
889
crainsnewyork article is is unusual in many ways, including that it continues CYDY's habit of totally unintelligible communications.

This article is behind a paywall so I can't access it but lorbas has provided at least part of the article.

1) Suddenly Pourhassan is reporting costs for CYDY human clinical trials. Why? Perhaps no reason at all.

2) Seethamraju and Pourhassan seem to collaborate with this interviewer. Perhaps they have always been collaborating more closely than has been reported.

3) "Next week when enrollment hits 75% the FDA could review" or whatever the statement was. Is this statement obviously seriously wrong and simply the result of the author's confusion? lorbas didn't paste that snippet from the article.

"Next week when enrollment hits 75% the FDA could review" is the latest unintelligible communication from Cytodyn.

I would say there are three important corrupted, unintelligible communications from Cytodyn in the last couple weeks:

1) crainsnewyork "Next week when enrollment hits 75% the FDA could review", attributed to Dr. Seethamraju.

2) Pourhassan on Nov 5 cc just past "FDA firewall biostatistician" is in possession of the CD12 data.

3) Seethamraju on Oct 15: "The FDA has CD12 interim results in its possession", which was then totally contradicted by Pourhassan a few days later in the Oct 20 CD12 conference call.

All three of these corrupted, unintelligible communications are related to the same topic: Does the FDA have information on the results of the CD12 interim analysis?

Seems to me that the least corrupted, most intelligible statement in that regard is Pourhassan's comments in the just past Nov 5 conference call.

At one point, around 45:00, Pourhassan clearly, unequivocally states that the "FDA firewall biostatistician" is in possession of CD12 results.

Who knows who or what a "FDA firewall statistician" might be, but apparently Pourhassan believes that this individual has CD12 results in their possession.

At around 48:00 in the call, Pourhassan provides more detail. Pourhassan asserts very strongly that one and only one person, the DSMC statistician, has seen the unblinded data. He then goes on to say that both the DSMC and the "FDA firewall biostastician" have seen the CD12 data.

Perhaps all of this fits together in the following scenario:

1) The only person to observe unblinded data, like names of patients and their outcomes, is the statistician working on behalf of the DSMC.

2) Bewteen Oct 15 and Oct 20, the unblinded DSMC statistician provides a summary report to the DSMC. Obviously, the DSMC gets some summary data or else the DSMC could not make an recommendations whatsoever.

3) At the same time, the same summary report provided to the DSMC was also provided to the "FDA firewall biostatistician", whoever and wherever they may be.

Supposing further that on Oct 15 Dr. Seethamraju knows the identity of the "FDA firewall biostatistician, and the Dr. Seethamraju also knows that the "FDA firewall boistatistician" was provided with the summary CD12 results, then Dr. Seethamraju is justified in making his comments on Oct 15 that "The FDA has the results of the CD12 interiam analysis."

But then during the Oct 20 CD12 conference call, Pourhassan insists that the CD12 interim results were not provided to the FDA, and goes further to emphasize that everyone is blinded except for the one statistician at Amarex. Perhaps on Oct 20 Pourhassan is claiming "no CD12 results to the FDA" on a logical technicality/ Perhaps Pourhassan's logical technicality is that the "FDA firewall biostatistician" is somehow not fully engaged with the rest of the FDA.

So that just leaves the crainsnewyork comment, attributed to Seethamraju, that FDA evaluation could begin next week with the enrollment of the 75th percentile patient.

Probably the crainsnewyork author was just confused by too much information and conflated the FDA participation in the 75% interim analysis with the enrollment of the 75th percentile patient.

Seethamraju's comments are always very aggressive as to timeframes. Maybe he is just pushing to get LL approved. Surely he has more patients and all he wants is to be able to treat them. Right now he has to put 1/3 of his patients on placebo. If he has some placebo patients dying he could be pissed.

I wonder if Seethamraju is blinded as to his patients' blood test results.

When Seethamraju has a CD12 patient, they get the injection but Seethamraju and the other Montefiore medical professionals are not told if the injection was LL or placebo.

However, at day 3, a blood draw is done for CCR5 receptor occupancy testing. Lab results are probably complete a few days later.

Are CCR5 receptor occupancy tests delivered to Dr. Seethamraju and the rest of the medical care team at Montefiore?

If yes, then Seethamraju knows with 100% certainty which of his patients are on LL and which are on placebo. The CCR5 receptor occupancy test is likely near 100% dispositive of whether a patient receied LL or placebo.

If Seethamraju is watching his placebo patients die at a greater rate than his LL patients that has to be a horrific situation for Dr. Seethamraju.

If Seethamraju is watching his patients die because they are not getting LL, then it is certainly understandable that he would be more aggressive with reports and timelines.

Is this the most probable scenario? Seethamraju has the CCR5 occupancy results for his dying patients. He knows Ll pateionts are better off than placebo patients.

Even though Seethamraju is unblinded by lab tests, he may be prohibited from telling anyone else.

The whole scenario is just so weird. CCR5 receptor occupancy blood tests are performed on Dr. Seethamraju's seriously ill and in some cases dying patients.

Its hard for me to believe that the CCR5 receptor occupancy blood tests are witheld from Dr. Seethamraju and the medical care team at Montefiore. But who knows.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 65

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 95

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Chicken Production Rises Amid Meat Market Shifts

Updated Category News Views 235

Protein Markets Scramble: Chicken Production Climbs Here’s a tasty tidbit that might just have investors reeling: the USDA says chicken production will be cruising on the up, whereas beef is taking a bit of a backseat. Yep, the big birds are flying higher, and the cows, well, they're just mooing a little softer. And what's that mean for big players like Tyson...

Continue Reading
USFM's Disko Deal Waits on Greenland Until March 2027

Updated Category News Views 61

A missing Greenland signature has turned USFM’s grand Disko plan into a calendar problem. Nothing more dramatic has been disclosed, but nothing less consequential should be assumed either. March 31 replaces a deadline that already failed USFM executed its share purchase agreement with 80 Mile PLC and Disko Exploration Limited on May 8, 2026. The proposed bargain is...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 97

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
NEDHSA Amplifies Tobacco-Free Push with 2026 Smokeout

Updated Category News Views 100

2026 Great American Smokeout: A Fresh Push Against Tobacco NEDHSA is sticking to its guns with a tobacco-free campaign that’s got deep roots. The 2026 Great American Smokeout, on November 19, not only highlights past efforts but looks to stir more folks into healthier habits. Beyond the campaign glitz, it’s about dragging a century-long bad habit further into the...

Continue Reading
Legato Frames Put Tiny AI to a Real-World Hearing Test

Updated Category News Views 100

A hearing aid that never enters the ear is a deceptively brutal product challenge. It has to hear speech through a mess of restaurant clatter, traffic, wind and ordinary human commotion; it has to run all day; and, crucially, it cannot look like a medical concession somebody reluctantly straps on. Legato Frames are aiming right at that knot, with femtoAI providing the...

Continue Reading
Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 114

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 66

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading

Top 5 Most Recently Viewed Articles

Taiwan Semiconductor's Arizona Facility Achieves First Profit

Updated Category News Views 276

Taiwan Semiconductor Celebrates Profit Milestone Taiwan Semiconductor Manufacturing Co. (NYSE: TSM) has made headlines with the profitable operation of its Arizona unit, marking a significant achievement. This milestone indicates robust performance, reinforcing its competitive position amidst increasing challenges from rivals like Samsung and Intel. Arizona Unit Sees...

Continue Reading
Greece Market Overview: Athens Composite Declines Amid Sector Losses

Updated Category News Views 54

Market Overview In the latest trading session, Greece's stock market faced a downturn, resulting in the Athens General Composite index experiencing a decline of 0.57%. This downturn was primarily influenced by poor performances across various sectors, notably Telecoms, Household, and Basic Resources. Such shifts in sector performance are vital indicators for investors...

Continue Reading
Charter Communications Adjusts Spectrum Internet Advertising Claims

Updated Category News Views 190

Charter Communications Adjusts Spectrum Internet Advertising Claims In a significant development for online advertising standards, Charter Communications, Inc. is adjusting its language regarding the claims made about Spectrum's internet service. The recommendation comes from the National Advertising Division (NAD) following a challenge raised by AT&T Services, Inc. The...

Continue Reading
Mitsubishi Electric Introduces High-Performance HVIGBT Modules

Updated Category News Views 252

Mitsubishi Electric to Launch New S1-Series HVIGBT Modules Mitsubishi Electric Corporation (TOKYO: 6503) has announced its plans to ship samples of two cutting-edge S1-Series High Voltage Insulated Gate Bipolar Transistor (HVIGBT) modules. These modules, rated at 1.7kV, are specifically engineered for large industrial applications including railcars and DC power...

Continue Reading
Celebrating Legacy: The Rich Passan Sports Writing Scholarship

Updated Category News Views 494

Introducing the Rich Passan Sports Writing Scholarship The National Press Club is excited to unveil the Rich Passan Sports Writing Scholarship, an annual commitment of $5,000 aimed at supporting aspiring undergraduate students who display outstanding talent and promise in sports journalism. This initiative embodies the dedication to nurturing young talent and upholding...

Continue Reading